Ariela Noy MD

12/10/2025

So great to be part of a team presenting all of this at ASH 2025!

I moderated the 626 Session on real world outcomes in aggressive B cell lymphoma and had two first author posters. Taught at the Medscape spotlight on rare disease about iMCD. Presented at international network and much more.

12/10/2025

Warrior Award for the Physician of the Year at

Castleman disease, collaborative network


Here with the leader of it all, David Fajgenbaum.

We also presented this at the meeting
Noy et al.
Retrospective real-world data analysis of morbidity burden and healthcare costs in idiopathic multicentric castleman disease compared with matched controls (BURDEN-iMCD).

And on Friday we did a Medscape on rare diseases where I taught about the management of iMCD.

12/10/2025

Just back from the American Society of Hematology.
Here is a poster I presented on plasmablastic lymphoma. The trial is now in a randomized phase. Participants all get EPOCH and half are getting daratumumab.

https://www.mskcc.org/cancer-care/clinical-trials/20-033

12/04/2025

Game changer for marginal zone lymphoma!
Congratulations to my MSK colleague M Lia Palomba and all involved!

The U.S. Food and Drug Administration today approved a new indication for Breyanzi (Lisocabtagene maraleucel) as the first Chimeric Antigen Receptor (CAR) T-cell therapy in the U.S.

11/20/2025

Hot off the presses! Congratulations to Dr. Lorenzo Falchi at MSK and all the other investigators and participants and research teams!

FDA approves epcoritamab-bysp for follicular lymphoma indications

10/12/2025

https://www.youtube.com/watch?v=hm4ZGze5KGo

Ariela Noy, MD, Memorial Sloan Kettering Cancer Center, New York, NY, shares insights into the management of Burkitt lymphoma, highlighting the importance of...

09/19/2025

Thank you to the AIDS Health Foundation for having me speak on HIV and Cancer: from depair to equity and ongoing research!

09/19/2025

Thank you to the Society of Hematologic Oncology for the opportunity to speak at their annual conference about Burkitt lymphoma in Houston Texas! Stay tuned for developments on our upcoming trial!

06/21/2025

At the International Conference for Malignant Lymphoma (ICML) Lugano meeting with Raphael Steiner and Paul Rubinstein.

04/25/2025

Happening today and tomorrow.
So great to be speaking with such esteemed colleagues from MSK and beyond. Speaking about Burkitt lymphoma tomorrow.

03/14/2025

This happened today. FANTASTIC opportunity to teach about tumor lysis syndrome.

03/05/2025

Support rare cancer research at Memorial Sloan Kettering Cancer Center.